EFAI Intelligent Cardiothoracic Ratio (iCTR) Assessment System is an AI-enabled medical device from Ever Fortune. AI Co., Ltd., listed by FDA (510(k), K212624) with a decision date of 2022-04-04. Review panel: Radiology.
| FDA submission number | K212624 |
|---|---|
| Pathway | 510(k) |
| Company | Ever Fortune. AI Co., Ltd. |
| Review panel (specialty) | Radiology |
| FDA decision date | 2022-04-04 |
| Decision | Substantially Equivalent |
| Product code | QIH |
| Classification | Automated Radiological Image Processing Software |
| Device class | 2 |
| Regulation number | 892.2050 |
| Review time (calendar days) | 229 |
| Applicant country | TW |
Official FDA database record · FDA AI-enabled device list
More devices from Ever Fortune. AI Co., Ltd. · All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.